Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
Cross-lab reproducibility verification and confidence receipts for consumer DNA test kits and home diagnostic lab results.
AI Thinking Process
Consumer DNA and home diagnostic kits (Everlywell, LetsGetChecked, 23andMe health panels) have known inter-lab reproducibility problems. Scientific reproducibility verification exists in academic research contexts. Verb Transplant: issue a 'reproducibility receipt' to consumers showing how their test results compare to same-sample cross-lab runs.
Distribution check: who buys this? Consumer directly — no formal buyer, Reddit health communities are not procurement channels. Consumer lab vendors (Everlywell, LetsGetChecked) — inverse incentive, cross-lab verification exposes their variability. Clinical reseller (Rupa Health) — Rupa already provides lab quality signals as a built-in feature to functional medicine practitioners.
KILLED: distribution failure. No procurement-capable buyer with budget. All pivots either occupied or structurally inverse-incentive. Direct-to-consumer reproducibility is a content/media business (articles, YouTube), not a SaaS product.
Kill Reason
No formal trust community with procurement budget (Reddit forums and patient advocacy groups are not procurement channels). Consumer lab kit vendors have inverse incentives against cross-lab verification. Clinical reseller pivot via Rupa Health is already occupied — Rupa provides quality signals on labs as a feature to functional medicine practitioners.
Risk Analysis
Risk analysis available for latest engine ideas.
Loading...
Related ideas you can explore free:
killed: Passive voice-based depression detection requires FDA Software as a Medical Device clearance for any diagnostic claim; a "wellness" framing undercuts the core value proposition and reduces willingness to pay. Epic Systems and large telehealth platforms are already integrating validated mental health screening tools into clinical workflows, crowding out standalone apps before they achieve scale.
killed: Google Nest Hub's built-in Soli radar-based sleep sensing already delivers contactless respiratory monitoring in millions of households, and Withings has shipped FDA-cleared sleep apnea screening hardware. A standalone $30 WiFi module cannot match the distribution, brand trust, or regulatory standing of these well-resourced incumbents.
killed: Urine and stool analysis for glucose monitoring, cancer screening, and kidney function markers falls squarely into FDA Class II/III medical device territory, requiring clinical trials and 510(k) or PMA approval costing millions and taking years. The entire high-value use case — the reason anyone would buy this — is legally undeliverable without regulatory clearance the product cannot realistically obtain.